Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildren

被引:13
作者
Guay, M
Clouâtre, AM
Blackburn, M
Baron, G
De Wals, P
Roy, C
Desrochers, J
Milord, F
机构
[1] Regie Reg Sante & Serv Sociaux Monteregie, Direct Sante Publ Planificat & Evaluat, Longueuil, PQ J4K 2M3, Canada
[2] Univ Sherbrooke, Fac Med, Dept Sci Sante Communautaire, Sherbrooke, PQ J1K 2R1, Canada
[3] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada
[4] Hop Charles LeMoyne, Ctr Rech, Greenfield Pk, PQ, Canada
[5] Univ Sherbrooke, Fac Adm, Sherbrooke, PQ J1K 2R1, Canada
来源
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE | 2003年 / 94卷 / 01期
关键词
D O I
10.1007/BF03405055
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Context: In 1994, immunization against hepatitis B was implemented in schools in Quebec, targeting grade 4 students. in 1996-1997 and 1997-1998, one Local Community Service Centre (CLSC) replaced the school-based program in its district with vaccination offered in community clinics after school hours. The aim of the current study was to compare the effectiveness and costs of school-based and clinic-based programs. Methods: Vaccination coverage data were collected in the CLSC with the clinic-based program (CBP), and in three matched CLSCs with a school-based program (SBP), from 1994 to 2000. Surveys were conducted to estimate costs to parents, to schools and to CLSCs in 1997-1998. Results: With the implementation of the CBP, the vaccination coverage fell to 73%, compared with over 90% in the SBPs. Coverage increased to 90% when the CBP was abandoned. Costs to the CLSC were not much lower in the CBP. Societal costs were $63 per student vaccinated in the CBP, and less than or equal to$40 in the SBPs. Conclusion: Results demonstrate the advantage of a SBP over a CBP for the immunization of schoolchildren.
引用
收藏
页码:64 / 67
页数:4
相关论文
共 23 条
[1]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[2]   A REAPPRAISAL OF HEPATITIS-B VIRUS VACCINATION STRATEGIES USING COST-EFFECTIVENESS ANALYSIS [J].
BLOOM, BS ;
HILLMAN, AL ;
FENDRICK, AM ;
SCHWARTZ, JS .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :298-306
[3]   A HEPATITIS-B VACCINATION PROGRAM TARGETING ADOLESCENTS [J].
CASSIDY, WM ;
MAHONEY, FJ .
JOURNAL OF ADOLESCENT HEALTH, 1995, 17 (04) :244-247
[4]  
Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P605
[5]   The Denver school-based adolescent hepatitis B vaccination program: A cost analysis with risk simulation [J].
Deuson, RR ;
Hoektra, EJ ;
Sedjo, R ;
Bakker, G ;
Melinkovich, P ;
Daeke, D ;
Hammer, AL ;
Goldsman, D ;
Judson, FN .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (11) :1722-1727
[6]   ASSESSMENT OF A UNIVERSAL, SCHOOL-BASED HEPATITIS-B VACCINATION PROGRAM [J].
DOBSON, S ;
SCHEIFELE, D ;
BELL, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (15) :1209-1213
[7]  
Drummond M., 2015, METHODS EC EVALUATIO, V4
[8]   Comparative immunogenicity under held conditions of two recombinant hepatitis B vaccines in 8-10-year-old children [J].
Duval, B ;
Boulianne, N ;
De Serres, G ;
Laflamme, N ;
De Wals, P ;
Massé, R ;
Trudeau, G ;
Delage, G ;
Desjardins, L .
VACCINE, 2000, 18 (15) :1467-1472
[9]   Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis [J].
Garuz, R ;
Torrea, JL ;
Arnal, JM ;
Forcen, T ;
Trinxet, C ;
Anton, F ;
Antonanzas, F .
VACCINE, 1997, 15 (15) :1652-1660
[10]  
GYORKOS TW, 1994, CAN J PUBLIC HEALTH, V85, pS14